Page 75 - GlaxoSmithKline Pharmaceuticals AR 2012

71
GlaxoSmithKline Pharmaceuticals Limited
Consolidated Statement of Profit and Loss for the year ended
31st December, 2012
Note
No.
Rupees
in lakhs
Previous year
Rupees
in lakhs
Sale of products .. .. .. .. .. .. .. .. 2692,39.70 2433,06.89
Excise duty .. .. .. .. .. .. .. .. (70,98.42) (54,59.27)
Sale of products (net) .. .. .. .. .. .. .. 2621,41.28 2378,47.62
Other operating revenue .. .. .. .. .. .. .. 29,12.79 35,91.80
Revenue from operations .. .. .. .. .. .. .. 30 2650,54.07 2414,39.42
Other Income .. .. .. .. .. .. .. .. 31 174,30.94 145,28.17
Total Revenue .. 2824,85.01 2559,67.59
Cost of materials consumed .. .. .. .. .. .. .. 32 443,03.89 440,05.85
Purchases of traded goods .. .. .. .. .. .. .. 33 607,81.21 535,31.53
Changes in inventories of finished goods, work-in-progress and traded goods .. .. 35 53,45.55 (56,04.31)
Employee benefits expense .. .. .. .. .. .. .. 36 295,51.55 278,36.31
Depreciation expense .. .. .. .. .. .. .. 11 17,83.93 20,40.78
Other expenses .. .. .. .. .. .. .. .. 37 424,61.06 414,24.25
Total EXPENSES .. 1842,27.19 1632,34.41
Profit before exceptional items and tax .. .. .. .. .. 982,57.82 927,33.18
Exceptional Items .. .. .. .. .. .. .. .. 42 (148,21.70) (322,54.14)
Profit before Tax .. .. .. .. .. .. .. .. 834,36.12 604,79.04
Tax expense:
Current tax .. .. .. .. .. .. .. .. 297,56.27 188,40.74
Deferred tax.. .. .. .. .. .. .. .. (25,08.19) (5,05.00)
Fringe benefits tax – write back of provision for earlier years .. .. .. — (7,15.45)
Net Profit .. .. .. .. .. .. .. .. 561,88.04 428,58.75
Earnings per equity share (basic and diluted) (Rs.) .. .. .. .. 48
Face value Rs. 10 each. .. .. .. .. .. .. .. 66.34 50.60
The accompanying notes are an integral part of these consolidated financial statements
This is the Consolidated Statement of Profit and Loss referred to in our report of even date
For Price Waterhouse & Co., Bangalore
Firm Registration No. 007567S
Chartered Accountants
Asha Ramanathan
Partner
Membership No. 202660
For and on behalf of the Board
Vice-Chairman V. Thyagarajan
Managing Director Dr. H. B. Joshipura
Senior Executive Director M. B. Kapadia
Company Secretary A. A. Nadkarni
Mumbai, 19th February, 2013 Mumbai, 19th February, 2013